Joseph Edelman, 10% Owner at Rain Therapeutics Inc. (RAIN), sold 97,252 shares at $14.80 ($1.3M) on 2021-10-07, disclosed to the SEC on 2021-10-13.
Open-market sale of $1.3M RAIN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.80 | 13,082 | $194K | 14.9% |
| 2 | $14.80 | 13,082 | $194K | 14.9% |
| 3 | $15.05 | 286 | $4K | 0.3% |
| 4 | $12.90 | 5,038 | $65K | 5.0% |
| 5 | $12.90 | 5,038 | $65K | 5.0% |
| 6 | $13.66 | 2,462 |
| $34K |
| 2.6% |
| 7 | $12.03 | 12,475 | $150K | 11.6% |
| 8 | $12.03 | 12,475 | $150K | 11.6% |
| 9 | $13.15 | 9,351 | $123K | 9.5% |
| 10 | $13.15 | 9,351 | $123K | 9.5% |
| 11 | $13.40 | 7,306 | $98K | 7.5% |
| 12 | $13.40 | 7,306 | $98K | 7.5% |
| Total | $13.34 avg | 97,252 | $1.3M | 100% |
| Filing → |
| MGTX | BUY | 2024-08-14 | $5.0M | — | Filing → |
| ALDX | BUY | 2024-04-08 | $1.7M | — | Filing → |
| ATHA | BUY | 2023-12-29 | $2.9M | — | Filing → |